Published in Lancet on October 10, 1987
11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action. Physiol Rev (2013) 1.60
Hypertension in mice lacking 11beta-hydroxysteroid dehydrogenase type 2. J Clin Invest (1999) 1.55
The Healing Effect of Licorice on Pseudomonas aeruginosa Infected Burn Wounds in Experimental Rat Model. World J Plast Surg (2014) 1.45
Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle. J Clin Invest (1988) 1.44
Mineralocorticoid receptors: distribution and activation. Heart Fail Rev (2005) 1.28
Glucocorticoid response elements and 11 beta-hydroxysteroid dehydrogenases in the regulation of endothelial nitric oxide synthase expression. Cardiovasc Res (2008) 1.15
Recycling between cortisol and cortisone in human splanchnic, subcutaneous adipose, and skeletal muscle tissues in vivo. Diabetes (2012) 1.13
11β-hydroxysteroid dehydrogenases and the brain: from zero to hero, a decade of progress. Front Neuroendocrinol (2010) 1.13
Aldosterone in the brain. Am J Physiol Renal Physiol (2009) 1.09
Steroid disorders in children: congenital adrenal hyperplasia and apparent mineralocorticoid excess. Proc Natl Acad Sci U S A (1999) 1.05
Licorice abuse: time to send a warning message. Ther Adv Endocrinol Metab (2012) 1.05
Renal medullary 11 beta-hydroxysteroid dehydrogenase type 1 in Dahl salt-sensitive hypertension. Physiol Genomics (2008) 1.04
11β-Hydroxysteroid dehydrogenase type 1, but not type 2, deficiency worsens acute inflammation and experimental arthritis in mice. Endocrinology (2011) 1.03
A switch in the mechanism of hypertension in the syndrome of apparent mineralocorticoid excess. J Am Soc Nephrol (2007) 1.01
Aldosterone synthesis in the brain contributes to Dahl salt-sensitive rat hypertension. Exp Physiol (2009) 0.99
Reduced activity of 11 beta-hydroxysteroid dehydrogenase in patients with cholestasis. J Clin Invest (2001) 0.99
Genetics of arterial hypertension and hypotension. Naunyn Schmiedebergs Arch Pharmacol (2007) 0.97
Prevalence and correlates of smoking on the roof of the world. Tob Control (2001) 0.92
The use of selected nutrition supplements and complementary and alternative medicine in liver disease. Nutr Clin Pract (2006) 0.89
Human hydroxysteroid dehydrogenases and pre-receptor regulation: insights into inhibitor design and evaluation. J Steroid Biochem Mol Biol (2011) 0.86
The multifaceted mineralocorticoid receptor. Compr Physiol (2014) 0.85
Crystal structures of 11β-hydroxysteroid dehydrogenase type 1 and their use in drug discovery. Future Med Chem (2011) 0.85
Molecular basis for hypertension in the "type II variant" of apparent mineralocorticoid excess. Am J Hum Genet (1998) 0.85
Is the mineralocorticoid receptor a potential target for stroke prevention? Clin Sci (Lond) (2008) 0.85
Can licorice lick colon cancer? J Clin Invest (2009) 0.85
The ubiquitous mineralocorticoid receptor: clinical implications. Curr Hypertens Rep (2012) 0.85
Diverse immunostaining patterns of mineralocorticoid receptor monoclonal antibodies. Steroids (2011) 0.84
Purification of 11 beta-hydroxysteroid dehydrogenase type 2 from human placenta utilizing a novel affinity labelling technique. Biochem J (1996) 0.83
Distribution of 11 beta-hydroxysteroid dehydrogenase along the rabbit nephron. J Clin Invest (1990) 0.82
Daily liquorice consumption for two weeks increases augmentation index and central systolic and diastolic blood pressure. PLoS One (2014) 0.82
Use of alternative medicines by patients with OA that adversely interact with commonly prescribed medications. Clin Orthop Relat Res (2009) 0.82
Reinvestigation of the effect of carbenoxolone on the induction of heat shock proteins. Cell Stress Chaperones (2009) 0.82
Role of mineralocorticoid action in the brain in salt-sensitive hypertension. Clin Exp Pharmacol Physiol (2012) 0.81
A pharmacological screening approach for discovery of neuroprotective compounds in ischemic stroke. PLoS One (2013) 0.80
Glucocorticoid-induced osteoporosis - a disorder of mesenchymal stromal cells? Front Endocrinol (Lausanne) (2011) 0.79
11beta-hydroxysteroid dehydrogenase type II inhibition causes cerebrovascular remodeling and increases infarct size after cerebral ischemia. Endocrinology (2008) 0.79
Outcomes after the long interdialytic break: implications for the dialytic prescription. Semin Dial (2012) 0.79
Brain mineralocorticoid receptors in cognition and cardiovascular homeostasis. Steroids (2014) 0.78
Adamantyl ethanone pyridyl derivatives: potent and selective inhibitors of human 11β-hydroxysteroid dehydrogenase type 1. ChemMedChem (2011) 0.78
Severe metabolic alkalosis, hypokalemia, and respiratory acidosis induced by the Chinese herbal medicine yokukansan in an elderly patient with muscle weakness and drowsiness. CEN Case Rep (2012) 0.78
Discovery of adamantyl heterocyclic ketones as potent 11β-hydroxysteroid dehydrogenase type 1 inhibitors. ChemMedChem (2011) 0.77
Pseudoaldosteronism due to the concurrent use of two herbal medicines containing glycyrrhizin: interaction of glycyrrhizin with angiotensin-converting enzyme inhibitor. Clin Exp Nephrol (2006) 0.77
Dying for a cup of tea. BMJ Case Rep (2012) 0.75
Lower limb monoparesis due to liquorice consumption. NDT Plus (2010) 0.75
Altered Regulation of Type II 11β-hydroxysteroid Dehydrogenase in the Kidney of Rats with Experimental Hypertension. Electrolyte Blood Press (2007) 0.75
Metformin Increases Cortisol Regeneration by 11βHSD1 in Obese Men With and Without Type 2 Diabetes Mellitus. J Clin Endocrinol Metab (2016) 0.75
Liquorice: a root cause of secondary hypertension. JRSM Open (2017) 0.75
Maintaining K(+) balance on the low-Na(+), high-K(+) diet. Am J Physiol Renal Physiol (2016) 0.75
Self-induced myopathy. Postgrad Med J (1997) 0.75
Low-dose liquorice ingestion resulting in severe hypokalaemic paraparesis, rhabdomyolysis and nephrogenic diabetes insipidus. Clin Kidney J (2014) 0.75
Herbal Medicine Containing Licorice May Be Contraindicated for a Patient with an HSD11B2 Mutation. Evid Based Complement Alternat Med (2011) 0.75
Metabolism of F18, a Derivative of Calanolide A, in Human Liver Microsomes and Cytosol. Front Pharmacol (2017) 0.75
The association between consistent licorice ingestion, hypertension and hypokalaemia: a systematic review and meta-analysis. J Hum Hypertens (2017) 0.75
A Randomized Controlled Trial of Glycyrrhizin Plus Tenofovir vs. Tenofovir in Chronic Hepatitis B with Severe Acute Exacerbation. Clin Transl Gastroenterol (2017) 0.75
Characteristics of hypertension in premature infants with and without chronic lung disease: a long-term multi-center study. Pediatr Nephrol (2017) 0.75
Liquorice-induced hypokalaemia in patients treated with Yokukansan preparations: identification of the risk factors in a retrospective cohort study. BMJ Open (2017) 0.75
Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med (2001) 5.31
NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia (1997) 4.88
Glucocorticoid exposure in utero: new model for adult hypertension. Lancet (1993) 3.47
11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress. Proc Natl Acad Sci U S A (1997) 3.00
Comparative genome organization of vertebrates. The First International Workshop on Comparative Genome Organization. Mamm Genome (1996) 2.97
Potentiation of hydrocortisone activity in skin by glycyrrhetinic acid. Lancet (1990) 2.87
Childhood Cushing's syndrome induced by betamethasone nose drops, and repeat prescriptions. BMJ (1998) 2.59
Recent trends and clinical features of childhood vitamin D deficiency presenting to a children's hospital in Glasgow. Arch Dis Child (2010) 2.58
Vasopressin analogue DDAVP in diabetes insipidus: clinical and laboratory studies. Br Med J (1973) 2.41
Pain after breast surgery: a survey of 282 women. Pain (1996) 2.33
Licorice-induced hypermineralocorticoidism. N Engl J Med (1991) 2.23
Measurement of de novo hepatic lipogenesis in humans using stable isotopes. J Clin Invest (1991) 2.11
Galactorrhoea: successful treatment with reduction of plasma prolactin levels by brom-ergocryptine. Br Med J (1972) 2.07
Localisation of 11 beta-hydroxysteroid dehydrogenase--tissue specific protector of the mineralocorticoid receptor. Lancet (1988) 1.97
Clinical studies of multiple endocrine neoplasia type 1 (MEN1) QJM (1996) 1.93
Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes. Life Sci (2000) 1.85
Ras activation in human breast cancer. Breast Cancer Res Treat (2000) 1.83
Angiotensin-converting enzyme inhibitors: past, present, and bright future. Lancet (1985) 1.81
Characterization of reproductive endocrine disorders in women with epilepsy. J Clin Endocrinol Metab (2001) 1.81
Protein intake in pregnancy, placental glucocorticoid metabolism and the programming of hypertension in the rat. Placenta (1996) 1.75
Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function. Cell Immunol (2001) 1.74
ANTI-HSP60 and ANTI-HSP70 antibody levels and micro/ macrovascular complications in type 1 diabetes: the EURODIAB Study. J Intern Med (2009) 1.68
5 alpha-reductase activity in polycystic ovary syndrome. Lancet (1990) 1.68
Cutaneous vasoconstrictor response to glucocorticoids in asthma. Lancet (1991) 1.61
Lymphocyte stimulation in hepatitis B infections. N Engl J Med (1975) 1.60
Functional localization of single active ion channels on the surface of a living cell. Nat Cell Biol (2000) 1.60
Characterization of mutations in patients with multiple endocrine neoplasia type 1. Am J Hum Genet (1998) 1.59
Rotation and restricted use of antibiotics in a medical intensive care unit. Impact on the incidence of ventilator-associated pneumonia caused by antibiotic-resistant gram-negative bacteria. Am J Respir Crit Care Med (2000) 1.58
Placental 11 beta-hydroxysteroid dehydrogenase: a key regulator of fetal glucocorticoid exposure. Clin Endocrinol (Oxf) (1997) 1.58
Cloning of human 25-hydroxyvitamin D-1 alpha-hydroxylase and mutations causing vitamin D-dependent rickets type 1. Mol Endocrinol (1997) 1.57
Establishment and characterization of a human adrenocortical carcinoma cell line that expresses multiple pathways of steroid biosynthesis. Cancer Res (1990) 1.57
Percutaneous computed tomography-guided ethanol injection in aldosterone-producing adrenocortical adenoma. Eur J Endocrinol (1995) 1.56
Mineralocorticoid excess and inhibition of 11 beta-hydroxysteroid dehydrogenase in patients with ectopic ACTH syndrome. Clin Endocrinol (Oxf) (1992) 1.56
Hypertension in mice lacking 11beta-hydroxysteroid dehydrogenase type 2. J Clin Invest (1999) 1.55
Bronchoscopy with bronchoalveolar lavage via the laryngeal mask airway in high-risk hypoxemic immunosuppressed patients. Crit Care Med (2001) 1.53
Plasma prolactin activity in inappropriate lactation. Br Med J (1971) 1.46
Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle. J Clin Invest (1988) 1.44
Mineralocorticoid hypertension and congenital deficiency of 11 beta-hydroxysteroid dehydrogenase in a family with the syndrome of 'apparent' mineralocorticoid excess. Clin Endocrinol (Oxf) (1995) 1.44
Direct inhibition of ovarian steroidogenesis by cortisol and the modulatory role of 11 beta-hydroxysteroid dehydrogenase. Clin Endocrinol (Oxf) (1993) 1.43
Osmotic and non-osmotic regulation of thirst and vasopressin secretion in patients with compulsive water drinking. Clin Endocrinol (Oxf) (1991) 1.42
A synthetic macromolecule for sentinel node detection: (99m)Tc-DTPA-mannosyl-dextran. J Nucl Med (2001) 1.42
Plasma exchange in severe spinal attacks associated with neuromyelitis optica spectrum disorder. Mult Scler (2009) 1.41
A rational approach for assessing the hypothalamo-pituitary-adrenal axis. Lancet (1988) 1.40
CD34+AC133+ cells isolated from cord blood are highly enriched in long-term culture-initiating cells, NOD/SCID-repopulating cells and dendritic cell progenitors. Stem Cells (1998) 1.40
Cortisol metabolism in human obesity: impaired cortisone-->cortisol conversion in subjects with central adiposity. J Clin Endocrinol Metab (1999) 1.39
Sexual precocity in a 4 year old boy. BMJ (2010) 1.39
Direct assays for adrenal steroids in neonates. Ann Clin Biochem (1991) 1.39
Neonatal screening for congenital adrenal hyperplasia: a programme based on a novel direct radioimmunoassay for 17-hydroxyprogesterone in blood spots. J Endocrinol (1986) 1.38
11 beta-hydroxysteroid dehydrogenase is an exclusive 11 beta- reductase in primary cultures of rat hepatocytes: effect of physicochemical and hormonal manipulations. Endocrinology (1995) 1.38
Cerebral vasospasm following subarachnoid hemorrhage: effect of calcitonin gene-related peptide on middle cerebral artery velocities using transcranial Doppler sonography. Surg Neurol (1991) 1.38
Inhibition of 11-beta-hydroxysteroid dehydrogenase in pregnant rats and the programming of blood pressure in the offspring. Hypertension (1996) 1.37
Hydrolysis of dietary flavonoid glycosides by strains of intestinal Bacteroides from humans. Biochem J (1987) 1.36
11 beta-Hydroxysteroid dehydrogenase activity in Cushing's syndrome: explaining the mineralocorticoid excess state of the ectopic adrenocorticotropin syndrome. J Clin Endocrinol Metab (1995) 1.33
Profiling steroid hormones and urinary steroids. J Chromatogr (1986) 1.33
Role of low Km cyclic AMP phosphodiesterase inhibition in tracheal relaxation and bronchodilation in the guinea pig. J Pharmacol Exp Ther (1989) 1.33
Fulminant Guillain-Barré syndrome mimicking cerebral death: case report and literature review. Intensive Care Med (2000) 1.32
Cyclical combination chemotherapy and gonadal function. Retrospective study in males. Lancet (1979) 1.31
Apparent cortisone reductase deficiency: a unique form of hypercortisolism. J Clin Endocrinol Metab (1996) 1.30
Gas chromatographic - mass spectrometric methods for the detection and identification of anabolic steroid drugs. Br J Sports Med (1975) 1.29
The development of a radioimmunoassay and a plasma extraction method for vasopressin. J Endocrinol (1970) 1.28
X-linked ichthyosis: increased blood cholesterol sulfate and electrophoretic mobility of low-density lipoprotein. Science (1981) 1.26
Amenorrhoea, galactorrhoea, and primary hypothyroidism with high circulating levels of prolactin. Br Med J (1971) 1.25
Increased de novo hepatic lipogenesis in human immunodeficiency virus infection. J Clin Endocrinol Metab (1993) 1.24
Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man. Clin Endocrinol (Oxf) (1996) 1.23
Recessive inheritance of diabetes: the syndrome of diabetes insipidus, diabetes mellitus, optic atrophy and deafness. Q J Med (1976) 1.23
The relationship between circulating concentrations of C-reactive protein, inflammatory cytokines and cytokine receptors in patients with non-small-cell lung cancer. Br J Cancer (2004) 1.21
Carbenoxolone increases hepatic insulin sensitivity in man: a novel role for 11-oxosteroid reductase in enhancing glucocorticoid receptor activation. J Clin Endocrinol Metab (1995) 1.19
Metyrapone in long-term management of Cushing's disease. Br Med J (1977) 1.19
Galactorrhoea. Br Med J (1972) 1.19
Hormonal and metabolic responses to an enkephalin analogue in normal man. Lancet (1978) 1.18
Correctable subsets of primary aldosteronism. Primary adrenal hyperplasia and renin responsive adenoma. Am J Hypertens (1990) 1.17
Mechanisms of fructose-induced hypertriglyceridaemia in the rat. Activation of hepatic pyruvate dehydrogenase through inhibition of pyruvate dehydrogenase kinase. Biochem J (1992) 1.17
Augmentation of human influenza A virus-specific cytotoxic T lymphocyte memory by influenza vaccine and adjuvanted carriers (ISCOMS). Virology (1999) 1.15
11 beta-hydroxysteroid dehydrogenase bioactivity and messenger RNA expression in rat forebrain: localization in hypothalamus, hippocampus, and cortex. Endocrinology (1990) 1.14
Human placental 11 beta-hydroxysteroid dehydrogenase: evidence for and partial purification of a distinct NAD-dependent isoform. Endocrinology (1993) 1.14
Cloning and production of antisera to human placental 11 beta-hydroxysteroid dehydrogenase type 2. Biochem J (1996) 1.13
Cell volume measurement using scanning ion conductance microscopy. Biophys J (2000) 1.12
Human prolactin, its isolation, assay and clinical applications. Clin Endocrinol (Oxf) (1972) 1.12
Systemic capillary leak syndrome. Q J Med (1990) 1.12
The group separation of plasma and urinary steroids by column chromatography on sephadex LH-20. Clin Chim Acta (1973) 1.09
Measurement of endogenous synthesis of plasma cholesterol in rats and humans using MIDA. Am J Physiol (1993) 1.09
alpha 1d Adrenoceptor signaling is required for stimulus induced locomotor activity. Mol Psychiatry (2003) 1.08
Examination of genotype and phenotype relationships in 14 patients with apparent mineralocorticoid excess. J Clin Endocrinol Metab (1998) 1.08
Salivary cortisol and anxiety in recurrent aphthous stomatitis. J Oral Pathol Med (1996) 1.07
Effects of walking on body composition and cardiovascular function of middle-aged man. J Appl Physiol (1971) 1.07
Release of oxytocin and vasopressin by the human foetus during labour. Nature (1971) 1.07
Fluorescent dye-primer cycle sequencing using unpurified PCR products as templates; development of a protocol amenable to high-throughput DNA sequencing. Nucleic Acids Res (1995) 1.06
Apparent cortisone reductase deficiency: a functional defect in 11beta-hydroxysteroid dehydrogenase type 1. J Clin Endocrinol Metab (1999) 1.06
Stability of housekeeping genes in alveolar macrophages from COPD patients. Eur Respir J (2006) 1.06
Growth-promoting action and growth factor release by different platelet derivatives. Platelets (2013) 1.05
11 beta-Hydroxysteroid dehydrogenase in cultured hippocampal cells reactivates inert 11-dehydrocorticosterone, potentiating neurotoxicity. J Neurosci (1996) 1.05
Identification of bile acids in the serum and urine in cholestasis. Evidence for 6alpha-hydroxylation of bile acids in man. Biochem J (1976) 1.05
Water and electrolyte balance in subjects with a permanent ileostomy. Gut (1983) 1.05
Nocturnal growth hormone and gonadotrophin secretion in growth retarded children with Crohn's disease. Gut (1981) 1.05
The development and application of a direct radioimmunoassay for corticosterone. Steroids (1981) 1.04
Circulating testosterone, sex hormone binding globulin and prolactin in women with late onset or persistent acne vulgaris. Br J Dermatol (1982) 1.04